Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced its intention to bid for 14 specifications of 12 products in the 11th national centralized drug procurement in China scheduled for October 27, 2025 [1] Product Summary - The products intended for bidding include: - Dihydrocodeine injection (2ml:0.3g) [1] - Formoterol fumarate inhalation solution (2ml:20µg) [1] - Fluvoxamine maleate tablets (100mg and 50mg) [1] - Chlorzoxazone injection (8mg) [1] - Adrenaline hydrochloride injection (1ml:1mg) [1] - Bromhexine hydrochloride injection (2ml:4mg) [1] - Compound electrolyte injection (500ml) [1] - Compound electrolyte injection II (500ml and 1000ml) [1] - Nicorandil tablets (5mg) [1] - Salbutamol sulfate injection (1ml:0.5mg) [1] - Benidipine hydrochloride tablets (8mg) [1] - Sodium bicarbonate injection (50ml:4.2g) [1]
石四药集团(02005)十二个产品十四个品规拟中标第十一批全国药品集中采购